BR
Bapu Ramrao Chege
About Bapu Ramrao Chege
Data last updated:
Bapu Ramrao Chege is a Designated Partner at Glomerulus Pharma Llp (since 2025) and Designated Partner at Nu Kidney Superspeciality Llp (since 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Glomerulus Pharma Llp ACQ-6149 | Designated Partner | 18 Aug 2025 | 2025 | Active | |
| Nu Kidney Superspeciality Llp ACQ-3877 | Designated Partner | 04 Aug 2025 | 2025 | Active |
Board colleagues of Bapu Ramrao Chege
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahesh Shinde | 11228284 | Glomerulus Pharma Llp , Nu Kidney Superspeciality Llp | Designated Partner |
| Naser Nazeer Patel | 11228283 | Glomerulus Pharma Llp , Nu Kidney Superspeciality Llp | Designated Partner |
| Ramesh Kishanrao Jadhav | 11245042 | Glomerulus Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bapu Ramrao Chege
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bapu Ramrao Chege
Bapu Ramrao Chege currently holds 2 directorships: Glomerulus Pharma Llp (Designated Partner, since 18 Aug 2025); Nu Kidney Superspeciality Llp (Designated Partner, since 04 Aug 2025).
Bapu Ramrao Chege was first appointed on 04 Aug 2025 as Designated Partner at Nu Kidney Superspeciality Llp.
The current boards of Bapu Ramrao Chege's companies include Mahesh Shinde (Glomerulus Pharma Llp), Naser Nazeer Patel (Glomerulus Pharma Llp), Ramesh Kishanrao Jadhav (Glomerulus Pharma Llp).